Ankylosing spondylitis

Hypo-vitaminosis D in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus and Ankylosing Spondylitis Mohamed Ismail Abdel Kareem1, Reem Hamdy A Mohammed2*, Hanan Sayed M Abozaid3, Mohamed Moneer Rayanv4, Abeer Mohamed Mohamed5 and Nihal Ahmad Fathi6 1Rheumatology and Rehabiltation, Al-Azhar Faculty of Medicine Assuit Egypt 2Rheumatology and Rehabilitation, Kasr Alaini School of Medicine Cairo University Hospital, Cairo Egypt 3Rheumatology and Rehabilitation, Faculty of Medicine

Which body parts are affected? Ankylosing spondylitis usually starts in the sacroiliac joints, which connect the spine and the pelvis together. In fact, the telltale sign that joint inflammation is caused by AS, and not another type of arthritis, is chronic lower back pain that is worse in the morning, feels better after exercising, and seems to come and go in flares for no apparent reason. The pain can fluctuate from side to side in the sacroiliac joint. The inflammation can then spread upwards

Ankylosing Spondylitis Ankylosing Spondylitis, also called Bechterew’s Disease or Marie Strumpell Disease has been defined by the Spondylitis Association of America as “a form of arthritis that primarily affects the spine, although other joints can be affected. It causes severe inflammation of the spinal joints and in more advanced cases this inflammation can lead ankylosis- which is new bone formation in the spine- causing sections of the spine to fuse in a fixed, immobile positions”. (Spondylitis

Ankylosing spondylitis is caused by a malfunction of the immune system, in which immune system mistakenly attacks healthy cells in the body - in this case, the vertebrae. Scientists are not sure why this happens, but the nature of AS puts it in the category of “autoimmune diseases”. The potential cause for ankylosing spondylitis is • Genetic involvement, where patients have abnormal genes which are triggered when the body reacts to a stressful period in life, an infection, or something else

occur within the skeletal system. Among these diseases are ankylosing spondylitis and a herniated nucleus pulposus. Ankylosing Spondylitis is a type of arthritis that attacks the spine and, in some people, the joints of the arms and legs. The most common symptoms of ankylosing spondylitis are chronic pain and stiffness in the lower back, buttocks, and hips that usually develops slowly over several weeks or months (Ankylosing Spondylitis, 2016). People in their teens or 20s, particularly males, are

ANKYLOSING SPONDYLITIS Ankylosing spondylitis (AS) is one of those autoimmune conditions which cause stiffening of the spinal column. The vertebrae of the spine fuse into one fused bone. Ankylosing spondylitis is sometimes called bamboo spine disease, because the vertebral column looks like a bamboo shoot. Symptoms Typically, the first symptoms of AS are frequent pain and stiffness in the lower back and buttocks, which start gradually over the course of a few weeks or months. At first, uneasiness

Overview Ankylosing spondylitis is a genetic condition where the vertebrae mutate and fuse together to cause stiffness, pain and deformities. The condition mostly affects young men ranging in their teens to twenties. Early diagnosis is especially important to avoid cases of locked posture and/or spinal distortion. Definition & Facts The term ankylosing spondylitis derives its name from two words: the verb, “ankylose,” meaning to stiffen, and the noun, “spondylitis,” meaning backbone joint inflammation

2047 Ankylosing Spondylitis Instructor Michelle Earixson-Lamothe 12/04/2014 Definition Ankylosing Spondylitis is a form of arthritis; it is a chronic and progressive form of joint formation that usually affects the spine and the sacroiliac joints. The sacroiliac joints are located in the lower back where the sacrum, the bone directly above the tailbone meets the iliac bones, bones on either side of the upper buttocks. Over time, chronic inflammation of the spine, also known as "spondylitis" can

There are similarities and differences among the regulations addressing the approval process of biosimilar products within the United States, the European Union, South Korea and Japan. This paper will attempt to identify these similarities and differences and determine how best practices can be leveraged among the associated regulatory bodies. The regulatory responsibility of the Food and Drug Administration (FDA) dates back to 1906 with the passage of the 1906 Pure Food and Drugs Act. “The Pure

Biotechnology Paper Biotechnology products are the yield of engineering labors that process biological material and agents to produce a modified biological substance. Examples of biotechnology drugs are monoclonal antibodies and recombinant DNA. Monoclonal antibodies are important reagents in the treatment and diagnosis of disease. They have been used for diagnosis of pregnancy, detection of presence and concentration of drugs in the blood, histocompatibility assay, and detecting shed tumor antigens